- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Salem Today
By the People, for the People
Peanut Butter Recall Issued in Oregon
FDA classifies recall as 'Class II' for potential health risks
Published on Feb. 17, 2026
Got story updates? Submit your updates here. ›
The U.S. Food and Drug Administration (FDA) has issued a recall for certain peanut butter products distributed in Oregon, categorizing it as a 'Class II' recall. This means the products may cause temporary or medically reversible adverse health consequences, according to the FDA.
Why it matters
Peanut allergies are a common and potentially serious food allergy, so any recall of peanut-containing products is an important public health issue, especially for those living in the affected region of Oregon.
The details
The specific peanut butter products affected by the recall have not been named, but the FDA has determined they pose a health risk and are working with the manufacturer to remove them from store shelves in Oregon.
- The FDA issued the Class II recall on February 16, 2026.
The players
U.S. Food and Drug Administration (FDA)
The federal agency responsible for protecting public health by regulating food, drugs, and other products.
What’s next
The FDA is advising consumers in Oregon who have purchased the recalled peanut butter products to return them to the place of purchase for a full refund.
The takeaway
This recall highlights the importance of food safety regulations and the FDA's role in quickly identifying and addressing potential health risks from consumer products, especially for common allergens like peanuts.

